Skip to main content

IGHID Investigators Discuss Projects As New Academic Year Begins

September 1, 2022
Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases (IGHID) contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of...

Scientists Create Long-acting Injectable Drug Delivery System for Tuberculosis

August 31, 2022
Led by Martina Kovarova, PhD, Miriam Braunstein, PhD, and J. Victor Garcia, PhD, UNC School of Medicine researchers showed in vivo efficacy of a long-acting injectable formulation of the anti-TB drug rifabutin. Read more.

Sustained Efficacy of Long-Acting Cabotegravir for PrEP Among Cisgender Women – Findings from HPTN 084 Study

August 31, 2022
Researchers from the HIV Prevention Trials Network (HPTN) presented updated results from the HPTN 084 long-acting cabotegravir (CAB) for pre-exposure prophylaxis (PrEP) study at the AIDS 2022 conference in Montreal. New findings show reductions in HIV incidence were sustained in the 12 months following trial unblinding (November 5, 2020, through...

Addressing Racism’s Role in the US HIV Epidemic: Qualitative Findings from Three “Ending the HIV Epidemic” Prevention Projects

August 31, 2022
Researchers from the Institute for Global Health and Infectious Diseases, the Gillings School of Global Public Health, and Center for Health Equity Research reviewed qualitative data from three “Ending the HIV Epidemic” (EHE) projects, published in the July issue of Journal of Acquired Immune Deficiency Syndrome (JAIDS). In the article,...

Victoria Shelus Studies Antimalarial Drug Use and Practice at Drug Shops in Uganda

August 31, 2022
Victoria Shelus studies antimalarial drug use and practice at drug shops in Uganda, building on the work of Dr. Ross Boyce. In the remote villages of Bugoye sub-county at the foot of Uganda’s Rwenzori Mountains a rolling landscape stretches across lush river valleys and steep hillsides. It’s the kind of...

Juliano Receives $3.4 million to Study the Increase of Relapsing Malaria Species in Africa

August 31, 2022
Jonathan Juliano, MD, MPSH, Professor of Infectious Diseases and Associate Director of the Institute for Global Health and Infectious Diseases, with fellow IDEEL investigators Jessica Lin, MD, MSCR, and Jonathan Parr, MD, MPH, and co-PIs from the University of Florida (UF) and Centre Pasteur Cameroon, has received a $3.4 million...

Study shows the positive effect of preventative therapy for malaria is mediated by gestational weight gain, influenced by intestinal pathogens

August 2, 2022
Malaria in pregnancy (MiP) is a major public health problem with substantial risks for mothers and their babies. The combination treatment sulfadoxine-pyrimethamine (SP), given for intermittent preventive therapy of malaria in pregnancy (IPTp), is one of the few existing interventions that improve outcomes for both mother and baby, despite widespread SP-resistant malaria....

CDC renews five-year funding for vector-borne disease threats

August 2, 2022
The Center for Disease Control and Prevention (CDC) has announced the five-year funding renewal of the Southeastern Center for Vector-Borne Diseases (SECVBD), an interdisciplinary team of researchers that includes UNC’s Ross Boyce, MD, MSc, a member of the UNC Institute for Global Health & Infectious Diseases and assistant professor in...

STD Awareness in April: Infectious Disease Experts Are Working to Advance the Development of Vaccines for Sexually Transmitted Infections

April 20, 2022
During April, STD Awareness provides an opportunity to talk about STIs and encourage individuals to be proactive about their sexual health and promotes regular STI/HIV screening and testing. Although research in sexually transmitted infections (STIs) has evolved rapidly on multiple fronts, a critical remaining challenge is the development of safe and effective...

García Receives ISAR’s 2022 Diversity Speaker Award

April 7, 2022
J. Victor García-Martinez, PhD, professor in the Division of Infectious Diseases and the Department of Microbiology & Immunology and Director of the International Center for the Advancement of Translational Science was keynote lecturer at the 35th International Conference on Antiviral Research (ICAR) last month. During the conference he was presented...

LAM Foundation Names UNC ILD Center the First Rare Lung Disease Clinic in NC or Virginia.

March 14, 2022
Lymphangioleiomyomatosis (LAM) is a rare and progressive lung disease that primarily affects women and has no known cure. The University of North Carolina, Chapel Hill Interstitial Lung Disease Center (UNC ILD Center) is pleased to announce that UNC has been chosen to be the first LAM and Rare Lung Disease...

DVT Awareness Month: Spotlighting Hematology Trial That Serves COVID Patients, BRC’s Thrombosis Related Research

March 14, 2022
March is Deep-Vein Thrombosis (DVT) Awareness Month, a public health initiative that seeks to aid understanding of a commonly occurring and potentially life-threatening medical condition among the general population. DVT is commonly referred to as a blood clot (thrombus) that forms in one or more veins located deep inside the...